國立虎尾科技大學 |

Group-Sequential Clinical Trials with Multiple Co-Objectives

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Group-Sequential Clinical Trials with Multiple Co-Objectives/ by Toshimitsu Hamasaki, Koko Asakura, Scott R. Evans, Toshimitsu Ochiai.
作者:	Hamasaki, Toshimitsu.
其他作者:	Asakura, Koko.
面頁冊數:	IX, 113 p. 14 illus.online resource. :
Contained By:	Springer Nature eBook
標題:	Statistics . -
電子資源:	https://doi.org/10.1007/978-4-431-55900-9
ISBN:	9784431559009

Group-Sequential Clinical Trials with Multiple Co-Objectives
Hamasaki, Toshimitsu.

Group-Sequential Clinical Trials with Multiple Co-Objectives[electronic resource] /by Toshimitsu Hamasaki, Koko Asakura, Scott R. Evans, Toshimitsu Ochiai. - 1st ed. 2016. - IX, 113 p. 14 illus.online resource. - JSS Research Series in Statistics,2364-0057. - JSS Research Series in Statistics,.

1. Introduction -- 2. Early Stopping for Efficacy in Clinical Trials with multiple co-primary endpoints -- 3. Sample size recalculation based on observed effects at interim -- 4. Early stopping for futility in Clinical Trials with multiple co-primary endpoints -- 5. Early stopping for futility or Efficacy in Clinical Trials with multiple co-primary endpoints -- 6. Clinical Trials with multiple primary endpoints -- 7. Group-sequential designs for three-arm noninferiority clinical trials -- 8. Further development: topics not covered in this book.

This book focuses on group sequential methods for clinical trials with co-primary endpoints based on the decision-making frameworks for: (1) rejecting the null hypothesis (stopping for efficacy), (2) rejecting the alternative hypothesis (stopping for futility), and (3) rejecting the null or alternative hypothesis (stopping for either futility or efficacy), where the trial is designed to evaluate whether the intervention is superior to the control on all endpoints. For assessing futility, there are two fundamental approaches, i.e., the decision to stop for futility based on the conditional probability of rejecting the null hypothesis, and the other based on stopping boundaries using group sequential methods. In this book, the latter approach is discussed. The book also briefly deals with the group sequential methods for clinical trials designed to evaluate whether the intervention is superior to the control on at least one endpoint. In addition, the book describes sample size recalculation and the resulting effect on power and type I error rate. The book also describes group sequential strategies for three-arm clinical trials to demonstrate the non-inferiority of experimental intervention to actively control and to assess the assay sensitivity to placebo control.

ISBN: 9784431559009

Standard No.: 10.1007/978-4-431-55900-9doiSubjects--Topical Terms:

1253516
Statistics .

LC Class. No.: QA276-280

Dewey Class. No.: 519.5

Group-Sequential Clinical Trials with Multiple Co-Objectives
LDR:03228nam a22003975i 4500 001 981186
003 DE-He213
005 20200706082832.0
007 cr nn 008mamaa
008 201211s2016 ja | s |||| 0|eng d
020 $a 9784431559009 $9 978-4-431-55900-9
024 7 $a 10.1007/978-4-431-55900-9 $2 doi
035 $a 978-4-431-55900-9
050 4 $a QA276-280
072 7 $a PBT $2 bicssc
072 7 $a MAT029000 $2 bisacsh
072 7 $a PBT $2 thema
082 0 4 $a 519.5 $2 23
100 1 $a Hamasaki, Toshimitsu. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1110671
245 1 0 $a Group-Sequential Clinical Trials with Multiple Co-Objectives $h [electronic resource] / $c by Toshimitsu Hamasaki, Koko Asakura, Scott R. Evans, Toshimitsu Ochiai.
250 $a 1st ed. 2016.
264 1 $a Tokyo : $b Springer Japan : $b Imprint: Springer, $c 2016.
300 $a IX, 113 p. 14 illus. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a JSS Research Series in Statistics, $x 2364-0057
505 0 $a 1. Introduction -- 2. Early Stopping for Efficacy in Clinical Trials with multiple co-primary endpoints -- 3. Sample size recalculation based on observed effects at interim -- 4. Early stopping for futility in Clinical Trials with multiple co-primary endpoints -- 5. Early stopping for futility or Efficacy in Clinical Trials with multiple co-primary endpoints -- 6. Clinical Trials with multiple primary endpoints -- 7. Group-sequential designs for three-arm noninferiority clinical trials -- 8. Further development: topics not covered in this book.
520 $a This book focuses on group sequential methods for clinical trials with co-primary endpoints based on the decision-making frameworks for: (1) rejecting the null hypothesis (stopping for efficacy), (2) rejecting the alternative hypothesis (stopping for futility), and (3) rejecting the null or alternative hypothesis (stopping for either futility or efficacy), where the trial is designed to evaluate whether the intervention is superior to the control on all endpoints. For assessing futility, there are two fundamental approaches, i.e., the decision to stop for futility based on the conditional probability of rejecting the null hypothesis, and the other based on stopping boundaries using group sequential methods. In this book, the latter approach is discussed. The book also briefly deals with the group sequential methods for clinical trials designed to evaluate whether the intervention is superior to the control on at least one endpoint. In addition, the book describes sample size recalculation and the resulting effect on power and type I error rate. The book also describes group sequential strategies for three-arm clinical trials to demonstrate the non-inferiority of experimental intervention to actively control and to assess the assay sensitivity to placebo control.
650 0 $a Statistics . $3 1253516
650 1 4 $a Statistical Theory and Methods. $3 671396
650 2 4 $a Statistics for Life Sciences, Medicine, Health Sciences. $3 670172
650 2 4 $a Statistics for Social Sciences, Humanities, Law. $3 1211304
700 1 $a Asakura, Koko. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1273699
700 1 $a Evans, Scott R. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1256882
700 1 $a Ochiai, Toshimitsu. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1273700
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9784431558989
776 0 8 $i Printed edition: $z 9784431558996
830 0 $a JSS Research Series in Statistics, $x 2364-0057 $3 1255493
856 4 0 $u https://doi.org/10.1007/978-4-431-55900-9
912 $a ZDB-2-SMA
912 $a ZDB-2-SXMS
950 $a Mathematics and Statistics (SpringerNature-11649)
950 $a Mathematics and Statistics (R0) (SpringerNature-43713)